NfL is a structural intermediate filament within axons and has been well established as a diagnostic and also promising prognostic biomarker of neuroaxonal destruction in various neurological diseases affecting the central nervous system (CNS) as known for multiple sclerosis, and peripheral nervous system (PNS) as neuropathies.15, 16, 17. This evidence concerns the gene NEFL and multiple sclerosis.